Drugmaker Lee Pharma has received marketing authorisation for its joint support supplement Bio-Cartilage Smoothwalk Tablets in the United Arab Emirates.
Describing it as a milestone, the Hyderabad-based company said it is the first product in the nutraceutical segment from India to get approved in the UAE. Bio-Cartilage Smoothwalk Tablets are already being used in India by those suffering from painful and progressive arthritis, director Alla Leela Rani said on Friday.
The company said it is a novel composition of bio nutraceuticals with potent phyto nutrients to prevent joint and connective tissue disorders. The product contains collagen type II, natural egg shell membrane, Boswellia and curcumin with vitamin D3 which mainly acts on joint and connective tissue disorders to increase cartilage in joints.
The product is under registration in all Middle East, East Asian countries. The company plans to file dossier, for marketing authorisation, in the U.S. in the second half of 2024.
EOM
